Victoria Franklin

Dr. Victoria Franklin

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2006 in Diabetic Medicine
Verified
Journal Article
Closed access
PDF file
Victoria FranklinVictoria Franklin
Victoria Franklin
AWAnnalu Walller
Annalu Walller
CPC. Pagliari
C. Pagliari
SGS. A. Greene
S. A. Greene

30 June 2008 in Journal of Medical Internet Research
Verified
Journal Article
Open access
Victoria FranklinVictoria Franklin
Victoria Franklin
AGAlexandra Greene
Alexandra Greene
AWAnnalu Walller
Annalu Walller
SGStephen Alan Greene
Stephen Alan Greene
CPClaudia Pagliari
Claudia Pagliari
Patients’ Engagement With “Sweet Talk” – A Text Messaging Support System for Young People With Diabetes

1 December 2003 in Diabetes Technology & Therapeutics
Verified
Journal Article
Closed access
Victoria FranklinVictoria Franklin
Victoria Franklin
AWAnnalu Walller
Annalu Walller
CPClaudia Pagliari
Claudia Pagliari
SGStephen Greene
Stephen Greene
Optimal diabetes management involves considerable behavioural modification, while nonadherence contributes significantly to poor glycaemia. Extensive research on psychological interventions aiming to improve glycaemia suggests that current strategies are costly and time-consuming and in our experience do not appeal to young people with Type 1 diabetes. Text messaging has rapidly become a socially popular form of communication. It is personal, highly transportable, and widely used, particularly in the adolescent population. However, text messaging coupled with specific behavioural health strategies has yet to be utilised effectively. We have developed a novel support network ("Sweet Talk"), based on a unique text-messaging system designed to deliver individually targeted messages and general diabetes information. Individualised motivation strategies—based on social cognition theory, the health belief model, and goal setting—form the theoretical basis of the message content. Intensifying insulin therapy and increasing contact with the diabetes team can improve control, but are difficult to provide within existing resources. Our support system offers a means of contact and support between clinic visits and aims to increase adherence with intensive insulin regimens and to improve clinical outcome.


27 March 2016 in Journal of Diabetes Science and Technology
Verified
Journal Article
Open access
Victoria FranklinVictoria Franklin
Victoria Franklin
The majority of people with type 1 diabetes have suboptimal glycemic control, increasing their complication risk. Technology to support diabetes self-care has advanced significantly and includes self-monitoring of blood glucose (SMBG), insulin pump therapy (IPT), continuous glucose monitoring (CGM), and sensor-augmented pump therapy (SAPT), which are stepping stones toward the “artificial pancreas” using closed-loop technology. Use of these technologies improves clinical outcomes for patients with the appropriate skills and motivation. This review addresses the psychosocial factors that influence both technology provision and clinical outcome and also how technology impacts on psychological outcomes. Optimal use of the various diabetes self-management technologies is influenced by previous self-care behaviors, demographic and psychological factors. Provision of IPT is also influenced by the same factors. Despite technology increasing the complexity of treatment, the lack of evidence for adverse psychological outcomes is reassuring. Treatment satisfaction is high, and discontinuation rates are low. However, technology will widen the health inequality gap if its use is limited to motivated patients who demonstrate good self-care behaviors. Pivotal to the success of the various technologies is provision of appropriate education at initiation of the technology, regular ongoing contact for treatment adjustments and trouble-shooting device issues plus access to psychological support when required. Additional support strategies may be required to help patients struggling with their diabetes to benefit from the available technology, recognizing that they may have most to gain.

27 November 2007 in Diabetologia
Verified
Journal Article
Closed access
PDF file
Victoria FranklinVictoria Franklin
Victoria Franklin
FKFaisel Khan
Faisel Khan
GKGwen Kennedy
Gwen Kennedy
Jill J.F BelchJill J.F Belch
Jill J.F Belch
SGS. A. Greene
S. A. Greene